Matthew S. Mazurek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Matthew S. Mazurek has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Agnes Soos
Institute of Biomaterials and Biomedical Engineering, University of Toronto, 164 College Street, Toronto, ON, Canada M5S 3G9
1 shared publication - Craig A. Simmons
University of Toronto
1 shared publication James R. Vallerand
Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
1 shared publication- Rachel K. Lim
Cumming School of Medicine, University of Calgary
1 shared publication - Ross E. B. Fitzsimmons
Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada
1 shared publication Sandra M. Ragheb
Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
1 shared publication
Latest Publications
- 1 June 2025
- Published by American College of Physicians in Annals of Internal Medicine: Clinical Cases
- Vol. 4 (6)
Gluten-Induced Hemoptysis: A Case Report of Lane–Hamilton Syndrome
- 1 June 2025
- Published by American College of Physicians in Annals of Internal Medicine: Clinical Cases
- Vol. 4 (6)
Gluten-Induced Hemoptysis: A Case Report of Lane–Hamilton Syndrome
- Open Access
- 19 August 2018
- Published by Wiley in Stem Cells International
- Vol. 2018, 1-16
Mesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue Engineering
As a result of over five decades of investigation, mesenchymal stromal/stem cells (MSCs) have emerged as a versatile and frequently utilized cell source in the fields of regenerative medicine and tissue engineering. In this review, we summarize the history of MSC research from the initial discovery of their multipotency to the more recent recognition of their perivascular identityin vivoand their extraordinary capacity for immunomodulation and angiogenic signaling. As well, we discuss long-standing questions regarding their developmental origins and their capacity for differentiation toward a range of cell lineages. We also highlight important considerations and potential risks involved with their isolation, ex vivo expansion, and clinical use. Overall, this review aims to serve as an overview of the breadth of research that has demonstrated the utility of MSCs in a wide range of clinical contexts and continues to unravel the mechanisms by which these cells exert their therapeutic effects.
- 19 August 2018
- Published by Wiley in Stem Cells International
- Vol. 2018, 1-16
Open AccessMesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue Engineering
As a result of over five decades of investigation, mesenchymal stromal/stem cells (MSCs) have emerged as a versatile and frequently utilized cell source in the fields of regenerative medicine and tissue engineering. In this review, we summarize the history of MSC research from the initial discovery of their multipotency to the more recent recognition of their perivascular identityin vivoand their extraordinary capacity for immunomodulation and angiogenic signaling. As well, we discuss long-standing questions regarding their developmental origins and their capacity for differentiation toward a range of cell lineages. We also highlight important considerations and potential risks involved with their isolation, ex vivo expansion, and clinical use. Overall, this review aims to serve as an overview of the breadth of research that has demonstrated the utility of MSCs in a wide range of clinical contexts and continues to unravel the mechanisms by which these cells exert their therapeutic effects.